Dong‐Hui Shin

429 total citations
13 papers, 353 citations indexed

About

Dong‐Hui Shin is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Dong‐Hui Shin has authored 13 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 2 papers in Pharmacology. Recurrent topics in Dong‐Hui Shin's work include Cancer Cells and Metastasis (3 papers), Wnt/β-catenin signaling in development and cancer (3 papers) and Hedgehog Signaling Pathway Studies (2 papers). Dong‐Hui Shin is often cited by papers focused on Cancer Cells and Metastasis (3 papers), Wnt/β-catenin signaling in development and cancer (3 papers) and Hedgehog Signaling Pathway Studies (2 papers). Dong‐Hui Shin collaborates with scholars based in South Korea, United States and Portugal. Dong‐Hui Shin's co-authors include Gu Kong, Hyun‐Jun Kim, Jeong‐Yeon Lee, Usawadee Dier, Nadine Hempel, Heekyoung Chung, Hee‐Young Won, Kun Ho Son, Su Jin Jeon and Youngmi Jung and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Cancer Research.

In The Last Decade

Dong‐Hui Shin

13 papers receiving 346 citations

Peers

Countries citing papers authored by Dong‐Hui Shin

Since Specialization

Citations

This map shows the geographic impact of Dong‐Hui Shin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong‐Hui Shin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong‐Hui Shin more than expected).

Fields of papers citing papers by Dong‐Hui Shin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong‐Hui Shin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong‐Hui Shin. The network helps show where Dong‐Hui Shin may publish in the future.

Co-authorship network of co-authors of Dong‐Hui Shin

This figure shows the co-authorship network connecting the top 25 collaborators of Dong‐Hui Shin. A scholar is included among the top collaborators of Dong‐Hui Shin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong‐Hui Shin. Dong‐Hui Shin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Comparing Left Ventricular Diastolic Function between Peritoneal Dialysis and Non-Dialysis Patients with Stage 5 Chronic Kidney Disease: A Propensity Score-Matched Analysis 2023 ·Journal of Clinical Medicine ·Byoung Geun Han, (unknown), Sooyeon Choi, Dong‐Hui Shin, Jae Seok Kim, (unknown)	1
2	MIG‐6 is essential for promoting glucose metabolic reprogramming and tumor growth in triple‐negative breast cancer 2021 ·EMBO Reports ·Jiabei He, Chien‐Feng Li, (unknown), Dong‐Hui Shin, (unknown), (unknown), Chia‐Hsin Chan	12
3	Increased expression and activity of Sod2 promotes transcoelomic metastasis in ovarian cancer 2018 ·Free Radical Biology and Medicine ·Yeon Kim, (unknown), Victoria Jones, Dong‐Hui Shin, Beth L. Worley, Rébécca Phaëton, Karthikeyan Mythreye, Nadine Hempel	1
4	MEL-18 loss mediates estrogen receptor–α downregulation and hormone independence 2015 ·Journal of Clinical Investigation ·Jeong‐Yeon Lee, Hee‐Young Won, Ji‐Hye Park, Hye‐Yeon Kim, Hee‐Joo Choi, Dong‐Hui Shin, Ju‐Hee Kang, Jong Kyu Woo, Seung-Hyun Oh, Taekwon Son, (unknown), Sehwan Kim, Hyung-Yong Kim, Kijong Yi, (unknown), Young‐Ha Oh, Gu Kong	27
5	Overexpression of Id1 in transgenic mice promotes mammary basal stem cell activity and breast tumorigenesis 2015 ·Oncotarget ·Dong‐Hui Shin, Ji‐Hye Park, Jeong‐Yeon Lee, Hee‐Young Won, Kiseok Jang, Kyueng‐Whan Min, Si‐Hyong Jang, Jong Kyu Woo, Seung Hyun Oh, Gu Kong	18
6	Bioenergetic Analysis of Ovarian Cancer Cell Lines: Profiling of Histological Subtypes and Identification of a Mitochondria-Defective Cell Line 2014 ·PLoS ONE ·Usawadee Dier, Dong‐Hui Shin, (unknown), (unknown), Nadine Hempel	75
7	Loss of Mel‐18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway 2012 ·The FASEB Journal ·Hee‐Young Won, Jeong‐Yeon Lee, Dong‐Hui Shin, (unknown), Jeong‐Seok Nam, (unknown), Gu Kong	45
8	The in vitro and in vivo anti‐tumor effect of KO‐202125, a sauristolactam derivative, as a novel epidermal growth factor receptor inhibitor in human breast cancer 2010 ·Cancer Science ·(unknown), (unknown), Dong‐Hui Shin, Ji‐Hye Park, (unknown), Hyun‐Jun Kim, Sung‐Dae Cho, Seung‐Hyun Oh, Young Ki Min, Gu Kong	2
9	Constitutive overexpression of Id‐1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution 2010 ·Journal of Cellular Physiology ·Dong‐Hui Shin, Si‐Hyong Jang, Byeong‐Cheol Kang, Hyun‐Jun Kim, Seung Hyun Oh, Gu Kong	9
10	Mel-18 Negatively Regulates INK4a/ARF-Independent Cell Cycle Progression via Akt Inactivation in Breast Cancer 2008 ·Cancer Research ·Jeong‐Yeon Lee, (unknown), Dong‐Hui Shin, (unknown), Hyun‐Jun Kim, Yong-Seok Kim, Gu Kong	40
11	Anticancer effects of wogonin in both estrogen receptor‐positive and ‐negative human breast cancer cell lines in vitro and in nude mice xenografts 2007 ·International Journal of Cancer ·Heekyoung Chung, Youngmi Jung, Dong‐Hui Shin, (unknown), (unknown), Hyun‐Jun Kim, (unknown), Su Jin Jeon, Kun Ho Son, Gu Kong	81
12	The in vitro and in vivo anti-tumor effect of decursin in estrogen receptor-negative human breast cancer cells occurs via downregulation of Akt signaling pathway 2007 ·Dong‐Hui Shin, Hyun‐Jun Kim, (unknown), Hak Sung Kim, Heekyoung Chung, Gu Kong	1
13	The antitumor effect of LJ-529, a novel agonist to A3 adenosine receptor, in both estrogen receptor–positive and estrogen receptor–negative human breast cancers 2006 ·Molecular Cancer Therapeutics ·Heekyoung Chung, Ji‐Youn Jung, Sung‐Dae Cho, (unknown), Hyun‐Jun Kim, Dong‐Hui Shin, Hwan Kim, Hea Ok Kim, Dae Hong Shin, Hyuk Woo Lee, Lak Shin Jeong, Gu Kong	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact